AGRX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 mai 2024 @ 21:58):

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States...

Stats
Dagens volum	43 478.00
Gjennomsnittsvolum	737 255
Markedsverdi	2.57M
EPS	$-1.510 ( 2024-03-28 )
Neste inntjeningsdato	( $-0.510 ) 2024-06-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0600
ATR14	$0.0140 (3.73%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-03	Coiante Scott M	Buy	20 000	Common Stock
2023-08-16	Coiante Scott M	Sell	0	Common Stock
2023-06-28	Welsh Amy	Buy	13 500	Common Stock
2023-06-28	Welsh Amy	Buy	4 500	Employee Stock Option (Right to Buy)
2023-06-28	Korner Paul	Buy	13 500	Common Stock

INSIDER POWER
99.60
Last 98 transactions
Buy: 13 666 273 \| Sell: 187 248

Agile Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner
CFRX	0.977
WISA	0.969
PXS	0.967
FWRD	0.967
IONM	0.964
PETS	0.962
IRDM	0.962
BHTG	0.961
CYXT	0.96
IVAC	0.959

10 Mest negative korrelasjoner
CRZN	-0.984
HERA	-0.981
AGGR	-0.98
HERAU	-0.979
LDHA	-0.978
TBSA	-0.976
LVRA	-0.976
ACQR	-0.974
LEGA	-0.974
AHRN	-0.973

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Agile Therapeutics Inc Økonomi

Annual	2023
Omsetning:	$19.59M
Bruttogevinst:	$10.62M (54.18 %)
EPS:	$-0.00670

FY	2023
Omsetning:	$19.59M
Bruttogevinst:	$10.62M (54.18 %)
EPS:	$-0.00670

FY	2022
Omsetning:	$10.88M
Bruttogevinst:	$4.05M (37.19 %)
EPS:	$-58.79

FY	2021
Omsetning:	$4.10M
Bruttogevinst:	$-6.62M (-161.35 %)
EPS:	$-0.884

Financial Reports:

No articles found.

Agile Therapeutics Inc

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.

Sanntidsoppdatering for Agile Therapeutics Inc [AGRX]

Upcoming Earnings Alert